Format

Send to

Choose Destination
See comment in PubMed Commons below
Trans Am Clin Climatol Assoc. 2012;123:126-33; discussion 133-4.

Pierre Ménétrier and his disease.

Author information

1
MRBIV, 2213 Garland Ave, Nashville, TN 37232-0441, USA. robert.coffey@vanderbilt.edu

Abstract

In 1888, Pierre Ménétrier first described the disease that bears his name. Many of the findings he reported then remain accepted features of the disease. Based on studies performed in our laboratory over the past 20 years, we have implicated increased transforming growth factor-α (TGFα) expression and heightened epidermal growth factor receptor (EGFR) activity in the pathogenesis of Ménétrier's disease. Herein, we provide a historical perspective of this rare disorder, review our experience with Ménétrier's disease, and discuss future challenges and opportunities posed by this disorder.

PMID:
23303980
PMCID:
PMC3540591
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center